 |
Diabetic Retinopathy
Research News and Information
Definition of 'Diabetic Retinopathy'Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION. Common names: Diabetic Retinopathy; Diabetic Retinopathies; Retinopathies, Diabetic; Retinopathy, Diabetic |
Saturday, November 21, 2009
Prediction of proliferative diabetic retinopathy with hemoglobin level.
30 Oct 2009 
OBJECTIVE: To investigate the role of hemoglobin (HGB) level in predicting proliferative diabetic retinopathy (PDR). METHODS: We assessed 426 individuals without PDR at baseline (213 men; 213 women) from the Pittsburgh Epidemiology of Diabetes ... Read more...
29 Sep 2009 OBJECTIVE: To report 5-year outcomes from a clinical trial of intravitreal triamcinolone acetonide (IVTA) in eyes with diabetic macular edema (DME) and impaired vision despite previous laser treatment. DESIGN: Prospective, double-masked, randomized ... Read more...
29 Sep 2009 OBJECTIVE: To quantify the effect on visual acuity of intravitreal triamcinolone for the treatment of laser-refractory diabetic macular edema (DME). STUDY DESIGN: Meta-analysis of eligible studies identified by searching MEDLINE, EMBASE, the ... Read more...
Latest indexed articles for 'Diabetic Retinopathy'
These are the very latest articles for this heading:
- Rapid and persistent regression of severe new vessels on the disc in proliferative diabetic retinopathy after a single intravitreal injection of pegaptanib.
16 Nov 2009 - Prediction of proliferative diabetic retinopathy with hemoglobin level. 30 Oct 2009
- Bevacizumab local complications. 30 Oct 2009
- Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema. 29 Sep 2009
- Visual acuity after intravitreal triamcinolone for diabetic macular edema refractory to laser treatment: a meta-analysis. 29 Sep 2009
- Renal and retinal effects of enalapril and losartan in type 1 diabetes. 29 Sep 2009
- Renal and retinal effects of enalapril and losartan in type 1 diabetes. 29 Sep 2009
- Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness. 17 Sep 2009
- Blindness in a 25-year follow-up of a population-based cohort of Danish type 1 diabetic patients. 8 Sep 2009
- Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy. 30 Aug 2009
- The -174GG interleukin-6 genotype is protective from retinopathy and nephropathy in juvenile onset type 1 diabetes mellitus. 30 Aug 2009
- The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy. 30 Aug 2009
- Diabetic macular edema. 30 Aug 2009
- Monitoring ocular drug therapy by analysis of aqueous samples. 20 Aug 2009
- Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study. 20 Aug 2009
- Foveal ganglion cell layer damage in ischemic diabetic maculopathy: correlation of optical coherence tomographic and anatomic changes. 19 Aug 2009
- Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial. 19 Aug 2009
- Comparison of the retinal microvasculature in European and African-Caribbean people with diabetes. 12 Aug 2009
- Intravitreal pegaptanib sodium (Macugen) for diabetic macular oedema. 10 Aug 2009
- [Subthreshold micropulse diode laser photocoagulation for diabetic macular edema with hard exudates] 30 Jul 2009
See a longer list of these articles.
Technical information about 'Diabetic Retinopathy'
Definition: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
Descriptor UI: D003930
Alternative terms: Diabetic Retinopathy; Diabetic Retinopathies; Retinopathies, Diabetic; Retinopathy, Diabetic;
Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;
Tree Number: C11.768.257; C14.907.320.382; C19.246.099.500.382;
Technical Notes: coordinate IM with specific type of diabetes mellitus (IM) if pertinent